Lv5
900 积分 2025-12-15 加入
Autologous transplantation of P63+ lung progenitor cells for chronic obstructive pulmonary disease therapy
9天前
已完结
CD20CAR-T Therapy Preemptively Treats Patients with Relapsed/Refractory DLBCL in Partial Remission after CD19CAR-T
12天前
已完结
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
13天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
CB-011, an Allogeneic Anti-BCMA CAR-T cell Therapy with Immune Cloaking, for Patients with relapsed/refractory Multiple Myeloma (r/r MM): Dose Escalation Results from the Cammouflage Phase 1 Trial
1个月前
已关闭
Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemia
1个月前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
2个月前
已完结
Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patients
2个月前
已完结
B cell checkpoints in autoimmune rheumatic diseases
2个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
2个月前
已完结
皖公网安备34019202002308
